- Canada House Wellness Group (CSE:CHV) subsidiary, Abba Medix, has added two new cannabis strains to its product portfolio
- The indica hybrids, Orange Dreamer and Cinnamon Twist, bring Abba’s product portfolio total up to seven
- Both strains are now available for sale to registered patients on the Abba website
- Canada House’s share price is down 12.5 per cent, and is currently trading at 3.5 cents per share
Canada House Wellness Group (CSE:CHV) subsidiary, Abba Medix, has introduced two new strains of medical cannabis to its product portfolio.
Orange Dreamer and Cinnamon Twist are indica dominant hybrids, which were screened in-house at Abba. Their addition to the company’s product offering now brings Abba’s strain portfolio total up to seven.
This latest update of the company’s strain portfolio comes hot on the heels of other exciting developments for Abba.
In early February, Abba signed two cannabis supply agreements in the same week. As a result, the company has greatly expanded its reach in Canadian provinces, including Alberta and British Columbia.
Abba’s President, and Canada House’s Chief Revenue Officer, Michael Orrbrooke, commented on the addition.
“As our medical patient base continues to grow, we will listen to their needs to ensure we build a full spectrum offering of diverse strains that meet their health and wellness needs.
“In addition to sourcing and phenotyping strains that our patients covet, we continue to focus on offering our products in new formats to further meet our patients’ needs,” he said.
Canada House CEO, Chris Churchill-Smith, also spoke about the company’s continuing progress.
“A key strategy in Canada House’s Path to Profitability is to increase Abba’s high-value medical patient base.
“Increasing our selection of cannabis products is paramount to servicing our patients while executing on this strategy,” he concluded.
Canada House’s share price is down 12.5 per cent, and is currently trading at 3.5 cents per share at 11:38am EST.
